Covaxin vaccine clinical studies canceled in Brazil

Brazil’s national sanitary regulator Anvisa definitively canceled the clinical studies on Indian vaccine Covaxin in Brazil. In a note released last night (Jul. 26), the agency said the measure was taken after Precisa stopped representing the vaccine in the country. “The decision was made after a technical assessment concluding that the end of Precisa’s  authorization to […]

Fonte